Cargando…
The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis
CD (cluster of differentiation) 69 and CD25 are considered early and late markers of the activation of lymphocytes, respectively. CD25 is a part of the IL-2 receptor and is present on the surface of immune and non-immune cells, with high amounts on activated lymphocytes and regulatory T cells. CD69...
Autores principales: | Adamczyk, Michał, Bartosińska, Joanna, Raczkiewicz, Dorota, Kowal, Małgorzata, Surdacka, Agata, Krasowska, Danuta, Michalak-Stoma, Anna, Krasowska, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607364/ https://www.ncbi.nlm.nih.gov/pubmed/37892710 http://dx.doi.org/10.3390/jcm12206573 |
Ejemplares similares
-
The Impact of Biologic Treatment on PD-1/PD-L1 Pathway Disturbances in Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023) -
IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity
por: Michalak-Stoma, Anna, et al.
Publicado: (2020) -
Suppressed Programmed Death 1 Expression on CD4(+) and CD8(+) T Cells in Psoriatic Patients
por: Bartosińska, Joanna, et al.
Publicado: (2017) -
Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients
por: Michalak-Stoma, Anna, et al.
Publicado: (2021) -
Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis
por: Michalak-Stoma, Anna, et al.
Publicado: (2022)